Iso­Plex­is aims to steer its 'bar­codes' to Nas­daq as Asia-fo­cused SPAC launch­es merg­er ef­forts

The biotech IPO train con­tin­ues steadi­ly chug­ging along, with a new pas­sen­ger punch­ing their tick­et late Tues­day.

Bran­ford, CT-based Iso­Plex­is is jump­ing aboard, sub­mit­ting its SEC pa­per­work with a $100 mil­lion ask pen­ciled in and aim­ing to bring its per­son­al­ized pro­tein “bar­codes” to Nas­daq. Tues­day’s S-1 comes a lit­tle over six months af­ter Iso­Plex­is nabbed a $135 mil­lion Se­ries D led by Per­cep­tive.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER